RXRX vs TEM
RXRX 与 TEM 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | RXRXRECURSION PHARMACEUTICALS, INC. | TEMTempus AI, Inc. |
|---|---|---|
| 市值 | $2.38B | $14.13M |
| 市净率 | — | 0.03 |
| 市销率 | 33.2x | 0.0x |
| 营收 | — | $1.51B(TTM) |
| 营收同比增长 | 26.9% | 83.4% |
| 净利润 | — | -$189.27M(TTM) |
| 净利同比增长 | -39.1% | 65.3% |
| 每股收益(稀释) | — | $-1.06(TTM) |
| 息税前利润率 | -867.9% | -19.9% |
| 净资产收益率 | -71.2% | -49.0% |
| 投入资本回报率 | -181.7% | — |
| 一年总回报 | -27.5% | -12.0% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:RXRX vs TEM
| 指标 | RXRX | TEM |
|---|---|---|
| 期末价值 | $4.1K | $19.5K |
| 总回报 | -58.6% | +95.0% |
| 年化收益 (CAGR) | -30.9% | +32.3% |
| 波动率 | 84.4% | 97.1% |
| 夏普比率 | -0.08 | 0.72 |
| 索提诺比率 | -0.12 | 1.15 |
| 最大回撤 | -73.9% | -59.8% |
基于 598 个共同交易日,2024-06-14 → 2026-11-02 · 无风险利率 4.21%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)